ZA200805411B - Aryl-isoxazolo-4-yl-oxadiazole derivatives - Google Patents

Aryl-isoxazolo-4-yl-oxadiazole derivatives

Info

Publication number
ZA200805411B
ZA200805411B ZA200805411A ZA200805411A ZA200805411B ZA 200805411 B ZA200805411 B ZA 200805411B ZA 200805411 A ZA200805411 A ZA 200805411A ZA 200805411 A ZA200805411 A ZA 200805411A ZA 200805411 B ZA200805411 B ZA 200805411B
Authority
ZA
South Africa
Prior art keywords
isoxazolo
aryl
oxadiazole derivatives
oxadiazole
derivatives
Prior art date
Application number
ZA200805411A
Other languages
English (en)
Inventor
Buettelmann Bernd
Han Bo
Knust Henner
Koblet Andreas
Thomas Andrew
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA200805411B publication Critical patent/ZA200805411B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA200805411A 2005-12-23 2008-06-20 Aryl-isoxazolo-4-yl-oxadiazole derivatives ZA200805411B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05112956 2005-12-23

Publications (1)

Publication Number Publication Date
ZA200805411B true ZA200805411B (en) 2009-07-29

Family

ID=37891460

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200805411A ZA200805411B (en) 2005-12-23 2008-06-20 Aryl-isoxazolo-4-yl-oxadiazole derivatives

Country Status (16)

Country Link
US (2) US7541372B2 (fr)
EP (1) EP1968972B1 (fr)
JP (1) JP5015172B2 (fr)
KR (1) KR101121240B1 (fr)
CN (1) CN101346372B (fr)
AR (1) AR058719A1 (fr)
AU (1) AU2006328602B2 (fr)
BR (1) BRPI0620146A2 (fr)
CA (1) CA2633425A1 (fr)
ES (1) ES2397401T3 (fr)
IL (1) IL192092A0 (fr)
NO (1) NO20082719L (fr)
RU (1) RU2426731C2 (fr)
TW (1) TWI324602B (fr)
WO (1) WO2007071598A1 (fr)
ZA (1) ZA200805411B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0620773A2 (pt) 2005-12-27 2011-11-22 Hoffmann La Roche derivados de aril-isoxazol-4-il-imidazol
US8492378B2 (en) 2006-08-03 2013-07-23 Takeda Pharmaceutical Company Limited GSK-3β inhibitor
EP2137158A4 (fr) * 2007-02-28 2012-04-18 Methylgene Inc Inhibiteurs à petite molécule de protéines arginine méthyltransférases (prmt)
FR2913886B1 (fr) 2007-03-22 2012-03-02 Guerbet Sa Utilisation de nanoparticules metalliques dans le diagnostique de la maladie d'alzheimer
SI2227467T1 (sl) * 2007-12-04 2015-03-31 F. Hoffmann-La Roche Ag Derivati izoksazolo-piridina
PT2913326T (pt) * 2008-05-14 2020-08-24 Scripps Research Inst Novos moduladores de recetores de fosfato de esfingosina
TW201033201A (en) * 2009-02-19 2010-09-16 Hoffmann La Roche Isoxazole-isoxazole and isoxazole-isothiazole derivatives
WO2010126002A1 (fr) * 2009-04-28 2010-11-04 塩野義製薬株式会社 Produit pharmaceutique contenant un composé sulfonamide hétérocyclique
JP2012180281A (ja) * 2009-06-29 2012-09-20 Dainippon Sumitomo Pharma Co Ltd 新規オキサジアゾール誘導体
PL2668183T3 (pl) * 2011-01-28 2018-10-31 Immunic Ag Inhibitowanie IL17 i IFN-gamma do leczenia zapalenia autoimmunologicznego
MX337721B (es) * 2011-09-19 2016-03-16 Suven Life Sciences Ltd Compuestos de heteroarilo como ligandos del receptor 5-ht4.
US8604062B2 (en) 2011-10-20 2013-12-10 Hoffman-La Roche Inc. Process for the preparation of isoxazolyl-methoxy nicotinic acids
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
WO2014001280A1 (fr) 2012-06-26 2014-01-03 Aniona Aps Dérivé de phényle triazole et son utilisation pour moduler le complexe du récepteur gabaa
IN2014DN11027A (fr) 2012-06-26 2015-09-25 Aniona Aps
WO2014001278A1 (fr) 2012-06-26 2014-01-03 Aniona Aps Dérivé de phényle triazole et son utilisation pour moduler le complexe du récepteur gabaa
WO2014001279A1 (fr) 2012-06-26 2014-01-03 Aniona Aps Dérivé de phényle triazole et son utilisation pour moduler le complexe du récepteur gabaa
EP2877463B1 (fr) 2012-06-26 2018-11-07 Saniona A/S Un dérivé phenyl-triazole et son utilisation pour la modulation du complexe du récepteur gabaa
EP3319968A1 (fr) 2015-07-06 2018-05-16 Rodin Therapeutics, Inc. N-aminophényl-amides hétérocycliques en tant qu'inhibiteurs de l'histone désacétylase
RS62639B1 (sr) 2015-07-06 2021-12-31 Alkermes Inc Hetero-halo inhibitori histonskih deacetilaza
RS62959B1 (sr) 2017-01-11 2022-03-31 Alkermes Inc Biciklični inhibitori histon-deacetilaze
CA3066423A1 (fr) * 2017-06-14 2018-12-20 Trevena, Inc. Composes pour moduler l'activite de s1p1 et leurs procedes d'utilisation
MD3664802T2 (ro) 2017-08-07 2022-07-31 Alkermes Inc Inhibitori biciclici ai deacetilazei histonei
IL275490B2 (en) 2017-12-22 2024-05-01 Ravenna Pharmaceuticals Inc Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
BR102019014802A2 (pt) 2018-07-20 2020-02-04 Boehringer Ingelheim Int difluorometil-fenil triazóis
TW202112767A (zh) 2019-06-17 2021-04-01 美商佩特拉製藥公司 作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物
CN114727977A (zh) 2019-11-19 2022-07-08 特维娜有限公司 化合物和化合物s1p1调节剂的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9808663D0 (en) * 1998-04-23 1998-06-24 Merck Sharp & Dohme Therapeutic agents
US6660753B2 (en) * 1999-08-19 2003-12-09 Nps Pharmaceuticals, Inc. Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
IT1314191B1 (it) 1999-10-18 2002-12-06 Recordati Chem Pharm Derivati isossazolcarbossamidici
PA8535601A1 (es) 2000-12-21 2002-11-28 Pfizer Derivados benzimidazol y piridilimidazol como ligandos para gabaa
GB0108475D0 (en) 2001-04-04 2001-05-23 Merck Sharp & Dohme New compounds
HUP0401880A2 (hu) 2001-07-05 2005-01-28 Synaptic Pharmaceutical Corporation Helyettesített anilin-piperidinek mint MCH-szelektív antagonisták, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
GB0128160D0 (en) * 2001-11-23 2002-01-16 Merck Sharp & Dohme Novel compounds
EP1773807A2 (fr) 2004-06-14 2007-04-18 Takeda San Diego, Inc. Inhibiteurs de kinase
US7351724B2 (en) * 2004-10-15 2008-04-01 The Scripps Research Institute Oxadiazole ketone inhibitors of fatty acid amide hydrolase
US20070060589A1 (en) * 2004-12-21 2007-03-15 Purandare Ashok V Inhibitors of protein arginine methyl transferases

Also Published As

Publication number Publication date
TW200732329A (en) 2007-09-01
TWI324602B (en) 2010-05-11
CN101346372A (zh) 2009-01-14
KR101121240B1 (ko) 2012-06-12
US20090197875A1 (en) 2009-08-06
WO2007071598A1 (fr) 2007-06-28
KR20080080213A (ko) 2008-09-02
AU2006328602A1 (en) 2007-06-28
ES2397401T3 (es) 2013-03-06
CN101346372B (zh) 2011-09-28
AR058719A1 (es) 2008-02-20
EP1968972B1 (fr) 2012-11-28
AU2006328602B2 (en) 2012-05-31
US7956074B2 (en) 2011-06-07
JP5015172B2 (ja) 2012-08-29
US20070161686A1 (en) 2007-07-12
RU2426731C2 (ru) 2011-08-20
NO20082719L (no) 2008-09-16
BRPI0620146A2 (pt) 2011-11-01
EP1968972A1 (fr) 2008-09-17
RU2008124198A (ru) 2010-01-27
JP2009520751A (ja) 2009-05-28
US7541372B2 (en) 2009-06-02
CA2633425A1 (fr) 2007-06-28
IL192092A0 (en) 2008-12-29

Similar Documents

Publication Publication Date Title
HUS2000022I1 (hu) Tiglien-3-on származékok
EP1878727A4 (fr) Dérivés de 2-aminoquinazoline
IL192092A0 (en) Aryl-isoxazolo-4-yl-oxadiazole derivatives
HK1129305A1 (zh) 取代的 -氨基-吡咯並三嗪衍生物
ZA200707358B (en) 1-benzylindole-2-carboxamide derivatives
EP1942105A4 (fr) Derive aminodihydrothiazine
PL1954674T3 (pl) Nowe pochodne N-fenetylokarboksyamidu
ZA200802421B (en) 1-Acyldihydropyrazol derivatives
ZA200802088B (en) 4-Phenyl-6-substitued-pyrimidine-2-carbonitrile derivatives
ZA200804257B (en) Azaindole-2-carboxamide derivatives
ZA200805353B (en) Aryl-isoxazol-4-yl-imidazole derivatives
IL184841A0 (en) Substituted aminoalkyl-and amidoalkyl-benzopyran derivatives
HK1115123A1 (en) Pyridylmethylsulfone derivative
IL191138A0 (en) Pyrazoloisoquinoline derivatives
ZA200711025B (en) N-dihydroxyalkyl-substituted 2-oxoimidazole derivative
GB0511410D0 (en) Benzotrizepinone derivatives
ZA200706577B (en) Dihydroimidazothiazole derivatives
ZA200708531B (en) Pyridylmethylsulfone derivative
IL184481A0 (en) Fluoroalkylpyrrolidine derivative
GB0500900D0 (en) Azaquinazoline derivatives
GB0514579D0 (en) Substituted benzyloxy-phenylmethylamide derivatives
AU3393P (en) Breakwell xTriticosecale
AU3401P (en) Archise Arctotis fastuosa
AU3292P (en) DP303 Dianella prunina
AU305159S (en) Ballpen